Researchers identify how cancer cells can 'hijack' treatments designed to kill them

By Bridie Smith
Updated June 8 2015 - 10:08am, first published June 2 2015 - 11:33pm
Rosmary Goulding's ovarian cancer has returned twice, illustrating the problems clinicians have when treating cancer. Photo: Justin McManus
Rosmary Goulding's ovarian cancer has returned twice, illustrating the problems clinicians have when treating cancer. Photo: Justin McManus

Australian researchers have identified four key ways by which one of the most common type of ovarian cancers becomes resistant to chemotherapy, a breakthrough which will better match patients with the most effective treatment.